Meningitis, Meningococcal: all 125 studies
Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.CompletedNCT03378258
- Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of AgeStatus unknownNCT02919293Phase 1/2
- Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsStatus unknownNCT02878291Phase 1
- Postmarketing Surveillance Study for Use of Menactra® in the Republic of KoreaCompletedNCT02864927Phase 4
- Conjugate Vaccine Against Meningococcus C a Brazilian ProjectStatus unknownNCT02858570Phase 2/3
- Ciprofloxacin for the Prevention of Meningococcal MeningitisCompletedNCT02724046Phase 4
- Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian FederationCompletedNCT02699840
- Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up StudyCompletedNCT02500511
- A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate VaccineStatus unknownNCT02481232Phase 1
- Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-ManguinhosCompletedNCT01889836Phase 1
- Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for MeningitisCompletedNCT01482052Phase 1
- Safety of MenACWY-CRM Vaccination in AdolescentsCompletedNCT01452464
- Safety Surveillance of MenACWY-CRM Vaccine in ChildrenCompletedNCT01452438
- Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in AdolescentsCompletedNCT01210885Phase 2
- Comparison of Two Meningococcal ACWY Conjugate VaccinesCompletedNCT01192997Phase 2/3
- Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 VaccineCompletedNCT00994695Phase 2
- Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy AdultsCompletedNCT00962624Phase 2
- Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In AdultsCompletedNCT00780806Phase 1/2
- Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in InfantsCompletedNCT00314041Phase 2
- Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy AdolescentsCompletedNCT00297817Phase 2
- Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy AdultsCompletedNCT00297687Phase 1
- Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide VaccineCompletedNCT00271479Phase 4
- Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal VaccineStatus unknownNCT00262015Phase 4
- Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216CompletedNCT00161941
- Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy InfantsCompletedNCT00161928Phase 3